Stay updated on Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page now shows the new revision label Revision: v3.7.0. A large set of previously visible terms—names of institutions and investigators, as well as study-related drugs and concepts—were removed, altering how the study is described and who is represented as involved.SummaryDifference19%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a newer version of the study entry. This appears to be an internal revision with no changes to the study details or visible content.SummaryDifference0.1%

- Check48 days agoChange DetectedStudy Record Dates were updated with several entries changing from Estimated to Actual, and the revision tag was updated to Revision: v3.6.5, indicating a new version of the study record.SummaryDifference0.4%

- Check62 days agoChange DetectedThe page shows a revision update from v3.6.3 to v3.6.4, indicating a software update to the site's tooling. It appears to affect only versioning metadata, not the study details.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a maintenance update. No visible study details or functionality appear to be altered.SummaryDifference0.1%

- Check90 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a small update to the page software or documentation. No study content or user-facing information was altered.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.